Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Heightened orofacial, manual, and gait variability in Parkinson's disease results from a general rhythmic impairment.

Puyjarinet F, Bégel V, Gény C, Driss V, Cuartero MC, Kotz SA, Pinto S, Dalla Bella S.

NPJ Parkinsons Dis. 2019 Sep 25;5:19. doi: 10.1038/s41531-019-0092-6. eCollection 2019.

2.

Rhythmic abilities and musical training in Parkinson's disease: do they help?

Cochen De Cock V, Dotov DG, Ihalainen P, Bégel V, Galtier F, Lebrun C, Picot MC, Driss V, Landragin N, Geny C, Bardy B, Dalla Bella S.

NPJ Parkinsons Dis. 2018 Mar 23;4:8. doi: 10.1038/s41531-018-0043-7. eCollection 2018.

3.

Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity.

Driss V, Leprêtre F, Briche I, Mopin A, Villenet C, Figeac M, Quesnel B, Brinster C.

Immunol Lett. 2017 Dec;192:27-34. doi: 10.1016/j.imlet.2017.10.004. Epub 2017 Oct 10.

PMID:
29030252
4.

Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis.

Thi THH, Priemel PA, Karrout Y, Driss V, Delbeke M, Dendooven A, Flament MP, Capron M, Siepmann J.

Int J Pharm. 2017 Nov 25;533(1):26-33. doi: 10.1016/j.ijpharm.2017.09.037. Epub 2017 Sep 18.

PMID:
28923765
5.

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model.

Mopin A, Driss V, Brinster C.

J Vis Exp. 2016 Oct 14;(116). doi: 10.3791/54270.

6.

Biologically-variable rhythmic auditory cues are superior to isochronous cues in fostering natural gait variability in Parkinson's disease.

Dotov DG, Bayard S, Cochen de Cock V, Geny C, Driss V, Garrigue G, Bardy B, Dalla Bella S.

Gait Posture. 2017 Jan;51:64-69. doi: 10.1016/j.gaitpost.2016.09.020. Epub 2016 Sep 28.

PMID:
27710836
7.

Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease.

Cochen De Cock V, Benard-Serre N, Driss V, Granier M, Charif M, Carlander B, Desplan M, Croisier Langenier M, Cugy D, Bayard S.

Sleep Med. 2015 Dec;16(12):1497-501. doi: 10.1016/j.sleep.2014.09.014. Epub 2015 Apr 14.

PMID:
26611947
8.

IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1.

Gatault S, Delbeke M, Driss V, Sarazin A, Dendooven A, Kahn JE, Lefèvre G, Capron M.

J Immunol. 2015 Sep 1;195(5):2483-92. doi: 10.4049/jimmunol.1402914. Epub 2015 Jul 27.

9.

The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.

Driss V, El Nady M, Delbeke M, Rousseaux C, Dubuquoy C, Sarazin A, Gatault S, Dendooven A, Riveau G, Colombel JF, Desreumaux P, Dubuquoy L, Capron M.

Mucosal Immunol. 2016 Mar;9(2):322-35. doi: 10.1038/mi.2015.62. Epub 2015 Jul 15.

10.

Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia.

Driss V, Quesnel B, Brinster C.

Eur J Immunol. 2015 Feb;45(2):396-406. doi: 10.1002/eji.201444736. Epub 2014 Dec 4.

11.

CR3-dependent negative regulation of human eosinophils by Mycobacterium bovis BCG lipoarabinomannan.

Driss V, Hermann E, Legrand F, Loiseau S, Delbeke M, Kremer L, Guerardel Y, Dombrowicz D, Capron M.

Immunol Lett. 2012 Apr 30;143(2):202-7. doi: 10.1016/j.imlet.2012.02.011. Epub 2012 Feb 25.

PMID:
22391042
12.

Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells.

Legrand F, Driss V, Delbeke M, Loiseau S, Hermann E, Dombrowicz D, Capron M.

J Immunol. 2010 Dec 15;185(12):7443-51. doi: 10.4049/jimmunol.1000446. Epub 2010 Nov 10.

13.

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N, Hetuin D, Quesnel B.

Cancer Immunol Immunother. 2010 Dec;59(12):1839-49. doi: 10.1007/s00262-010-0909-y. Epub 2010 Sep 4.

14.

[Eosinophil: a new effector of innate immunity?].

Driss V, Legrand F, Loiseau S, Capron M.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):621-6. doi: 10.1051/medsci/2010266-7621. Review. French.

15.

Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.

Kanda A, Driss V, Hornez N, Abdallah M, Roumier T, Abboud G, Legrand F, Staumont-Sallé D, Quéant S, Bertout J, Fleury S, Rémy P, Papin JP, Julia V, Capron M, Dombrowicz D.

J Allergy Clin Immunol. 2009 Sep;124(3):573-82, 582.e1-9. doi: 10.1016/j.jaci.2009.04.031. Epub 2009 Jun 21.

PMID:
19539982
16.

A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Legrand F, Driss V, Woerly G, Loiseau S, Hermann E, Fournié JJ, Héliot L, Mattot V, Soncin F, Gougeon ML, Dombrowicz D, Capron M.

PLoS One. 2009 Jun 17;4(6):e5926. doi: 10.1371/journal.pone.0005926.

17.

TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins.

Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, Kremer L, Adam E, Woerly G, Dombrowicz D, Capron M.

Blood. 2009 Apr 2;113(14):3235-44. doi: 10.1182/blood-2008-07-166595. Epub 2008 Oct 31.

PMID:
18978205
18.

Innate immune function of eosinophils: from antiparasite to antitumor cells.

Legrand F, Woerly G, Driss V, Capron M.

Methods Mol Biol. 2008;415:215-40. doi: 10.1007/978-1-59745-570-1_13.

PMID:
18370157

Supplemental Content

Support Center